Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Vium Inc.
Headquarters: San Mateo, CA, United States of America
Website: N/A
Year Founded: 2013
Status: Acquired
BioCentury | Aug 14, 2024
Deals
Deals Report: Pair of Merck deals in APAC region; Recursion and Exscientia merging
Plus: Denmark-based Pharmacosmos buys G1, obtaining myelosuppression drug
BioCentury | Apr 7, 2022
Deals
April 6 Quick Takes: Retro lands with $180M for multidisease prevention
Plus: Molecular glue play Triana debuts and updates from AZ-Harbour, BioXcel, Citius, Novartis, Sanofi
BioCentury | Aug 4, 2020
Product Development
Aug. 3 Quick Takes: CymaBay gains on PBC readout; plus expanded labels for Epidiolex, Spravato, Voyager-AbbVie deal ends, Immunic and more
BioCentury | Jan 3, 2019
Emerging Company Profile
Auransa’s AI-predicted pipeline
How Auransa is using AI to uncover and treat new patient subgroups
BioCentury | Jul 12, 2018
Strategy
HEAL-ing pain at NIH
How NIH is paving new pathways for developing non-addictive pain therapies
BioCentury | Feb 9, 2017
Tools & Techniques
Preclinical autopilot
How “cloud labs” aim to increase the efficiency and reliability of preclinical research
BioCentury | Jun 2, 2016
Strategy
Digital Preclinical
How Vium is automating data collection to overhaul in vivo research practices
Items per page:
1 - 7 of 7